DDO Antikörper (AA 37-161)
-
- Target Alle DDO Antikörper anzeigen
- DDO (D-Aspartate Oxidase (DDO))
-
Bindungsspezifität
- AA 37-161
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DDO Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Kreuzreaktivität
- Human, Ratte
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human D-aspartate oxidase protein (37-161AA)
- Isotyp
- IgG
- Top Product
- Discover our top product DDO Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- DDO (D-Aspartate Oxidase (DDO))
- Andere Bezeichnung
- DDO (DDO Produkte)
- Hintergrund
-
Background: Selectively catalyzes the oxidative deamination of D-aspartate and its N-methylated derivative, N-methyl D-aspartate.
Aliases: D aspartate oxidase antibody, D-aspartate oxidase antibody, DASOX antibody, DDO 1 antibody, DDO 2 antibody, DDO antibody, FLJ45203 antibody, OTTHUMP00000017000 antibody, OXDD_HUMAN antibody
- UniProt
- Q99489
-